These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26256868)

  • 1. [Roles of mTOR signalings in hematopoiesis and leukemogenesis].
    Hirao A
    Rinsho Ketsueki; 2015 Jun; 56(6):601-5. PubMed ID: 26256868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic / mammalian target protein of rapamycin signaling in hematopoietic stem cells and leukemia.
    Hirao A; Hoshii T
    Cancer Sci; 2013 Aug; 104(8):977-82. PubMed ID: 23648144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTORC signaling in hematopoiesis.
    Wang X; Chu Y; Wang W; Yuan W
    Int J Hematol; 2016 May; 103(5):510-8. PubMed ID: 26791377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic roles of mTOR complexes in haemato-lymphopoiesis and leukemogenesis.
    Hoshii T; Matsuda S; Hirao A
    J Biochem; 2014 Aug; 156(2):73-83. PubMed ID: 24962700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of cancer behavior mediated by mTOR signal].
    Hirao A
    Nihon Rinsho; 2015 May; 73(5):773-8. PubMed ID: 25985629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis.
    Kalaitzidis D; Sykes SM; Wang Z; Punt N; Tang Y; Ragu C; Sinha AU; Lane SW; Souza AL; Clish CB; Anastasiou D; Gilliland DG; Scadden DT; Guertin DA; Armstrong SA
    Cell Stem Cell; 2012 Sep; 11(3):429-39. PubMed ID: 22958934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TOR-centric concept of regulation mitogenic, metabolic and energetic signal processing in cell].
    Zubova SG; Shitikova ZhV; Pospelova TV
    Tsitologiia; 2012; 54(8):589-602. PubMed ID: 23074850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological Aspects of mTOR in Leukemia.
    Mirabilii S; Ricciardi MR; Piedimonte M; Gianfelici V; Bianchi MP; Tafuri A
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30110936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advances of studies on role of mTOR signaling in aging of hematopoietic and other organ systems-review].
    Hua CL; Cheng T; Yuan WP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1313-7. PubMed ID: 24156457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR in Brain Physiology and Pathologies.
    Bockaert J; Marin P
    Physiol Rev; 2015 Oct; 95(4):1157-87. PubMed ID: 26269525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian target of rapamycin and the kidney. I. The signaling pathway.
    Lieberthal W; Levine JS
    Am J Physiol Renal Physiol; 2012 Jul; 303(1):F1-10. PubMed ID: 22419691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.
    Yang H; Wang X; Zhang Y; Liu H; Liao J; Shao K; Chu Y; Liu G
    J Cell Physiol; 2014 Jan; 229(1):17-26. PubMed ID: 23804073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR-what does it do?
    Hall MN
    Transplant Proc; 2008 Dec; 40(10 Suppl):S5-8. PubMed ID: 19100909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current models of mammalian target of rapamycin complex 1 (mTORC1) activation by growth factors and amino acids.
    Zheng X; Liang Y; He Q; Yao R; Bao W; Bao L; Wang Y; Wang Z
    Int J Mol Sci; 2014 Nov; 15(11):20753-69. PubMed ID: 25402640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Akt-mTOR network at the interface of hematopoietic stem cell homeostasis.
    Wu F; Chen Z; Liu J; Hou Y
    Exp Hematol; 2021 Nov; 103():15-23. PubMed ID: 34464661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of SHP2 in hematopoiesis and leukemogenesis.
    Pandey R; Saxena M; Kapur R
    Curr Opin Hematol; 2017 Jul; 24(4):307-313. PubMed ID: 28306669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR Signaling in Growth, Metabolism, and Disease.
    Saxton RA; Sabatini DM
    Cell; 2017 Mar; 168(6):960-976. PubMed ID: 28283069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells.
    Xu RH; Pelicano H; Zhang H; Giles FJ; Keating MJ; Huang P
    Leukemia; 2005 Dec; 19(12):2153-8. PubMed ID: 16193082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.